{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T15:16:05Z","timestamp":1773933365223,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T00:00:00Z","timestamp":1669161600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.esmoop.2022.100743","type":"journal-article","created":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T11:58:40Z","timestamp":1671451120000},"page":"100743","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Development and validation of a risk score (Delay-7) to predict the occurrence of a treatment delay following cycle 1 chemotherapy"],"prefix":"10.1016","volume":"8","author":[{"given":"P.","family":"Chambers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.D.","family":"Forster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Kipps","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.C.K.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Jani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.esmoop.2022.100743_bib1","first-page":"605","article-title":"Treatment-related problems experienced by cancer patients undergoing chemotherapy: a scoping review","volume":"24","author":"Wagland","year":"2015","journal-title":"Eur J Cancer Care (Engl)"},{"key":"10.1016\/j.esmoop.2022.100743_bib2","doi-asserted-by":"crossref","first-page":"n1647","DOI":"10.1136\/bmj.n1647","article-title":"Real time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSMART)","volume":"374","author":"Maguire","year":"2021","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.esmoop.2022.100743_bib3","doi-asserted-by":"crossref","first-page":"e1609","DOI":"10.1002\/onco.13822","article-title":"Relative dose intensity of chemotherapy and survival in patients with advanced stage solid tumor cancer: a systematic review and meta-analysis","volume":"26","author":"Nielson","year":"2021","journal-title":"Oncologist"},{"issue":"10179","key":"10.1016\/j.esmoop.2022.100743_bib4","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/S0140-6736(18)33137-4","article-title":"Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials","volume":"393","author":"Gray","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.esmoop.2022.100743_bib5","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1200\/CCI.20.00081","article-title":"Clinical utility and user perceptions of a digital system for electronic patient-reported symptom monitoring during routine cancer care: findings from the PRO-TECT trial","volume":"4","author":"Basch","year":"2020","journal-title":"JCO Clin Cancer Inform"},{"issue":"9","key":"10.1016\/j.esmoop.2022.100743_bib6","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/s41416-018-0037-6","article-title":"Predicting cumulative incidence of adverse events in older patients with cancer undergoing first-line palliative chemotherapy: Korean Cancer Study Group (KCSG) multicentre prospective study","volume":"118","author":"Kim","year":"2018","journal-title":"Br J Cancer"},{"issue":"25","key":"10.1016\/j.esmoop.2022.100743_bib7","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1200\/JCO.2011.34.7625","article-title":"Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study","volume":"29","author":"Hurria","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"10.1016\/j.esmoop.2022.100743_bib8","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.12823","article-title":"Development and validation of a score to predict acute care use after initiation of systemic therapy for cancer","volume":"2","author":"Grant","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.esmoop.2022.100743_bib9","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/jamaoncol.2015.0828","article-title":"A\u00a0clinical prediction model to assess risk for chemotherapy-related hospitalization in patients initiating palliative chemotherapy","volume":"1","author":"Brooks","year":"2015","journal-title":"JAMA Oncol"},{"issue":"6","key":"10.1016\/j.esmoop.2022.100743_bib10","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1634\/theoncologist.10-6-427","article-title":"Risk models for predicting chemotherapy-induced neutropenia","volume":"10","author":"Lyman","year":"2005","journal-title":"Oncologist"},{"issue":"4","key":"10.1016\/j.esmoop.2022.100743_bib11","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00280-014-2416-x","article-title":"The impact of dose\/time modification in irinotecan- and oxaliplatin-based chemotherapies on outcomes in metastatic colorectal cancer","volume":"73","author":"Nakayama","year":"2014","journal-title":"Cancer Chemother Pharmacol"},{"issue":"3","key":"10.1016\/j.esmoop.2022.100743_bib12","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s10549-013-2582-2","article-title":"A\u00a0retrospective evaluation of chemotherapy dose intensity and supportive care for early-stage breast cancer in a curative setting","volume":"139","author":"Lyman","year":"2013","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"10.1016\/j.esmoop.2022.100743_bib13","first-page":"2413","article-title":"Patient factors and their impact on neutropenic events: a systematic review and meta-analysis","volume":"27","author":"Chambers","year":"2019","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.esmoop.2022.100743_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-014-0241-z","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement","volume":"13","author":"Collins","year":"2015","journal-title":"BMC Med"},{"key":"10.1016\/j.esmoop.2022.100743_bib16","doi-asserted-by":"crossref","first-page":"m441","DOI":"10.1136\/bmj.m441","article-title":"Calculating the sample size required for developing a clinical prediction model","volume":"368","author":"Riley","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.esmoop.2022.100743_bib17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1471-2288-14-75","article-title":"Tuning multiple imputation by predictive mean matching and local residual draws","volume":"14","author":"Morris","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.esmoop.2022.100743_bib18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s41512-019-0064-7","article-title":"A\u00a0simple, step-by-step guide to interpreting decision curve analysis","volume":"3","author":"Vickers","year":"2019","journal-title":"Diagn Progn Res"},{"issue":"6","key":"10.1016\/j.esmoop.2022.100743_bib19","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S1470-2045(19)30163-9","article-title":"Estimates of global chemotherapy demands and corresponding physician workforce requirements for 2018 and 2040: a population-based study","volume":"20","author":"Wilson","year":"2019","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.esmoop.2022.100743_bib20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.7748\/cnp.15.9.19.s20","article-title":"Good practice guideline: promoting early identification of systemic anti-cancer therapies side effects: two approaches","volume":"15","author":"Oakley","year":"2016","journal-title":"Cancer Nurs Pract"},{"issue":"34","key":"10.1016\/j.esmoop.2022.100743_bib21","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1200\/JCO.21.01236","article-title":"A\u00a0validated risk prediction model for breast cancer in US black women","volume":"39","author":"Palmer","year":"2021","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.esmoop.2022.100743_bib22","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s12288-016-0730-7","article-title":"Validation of MASCC score for risk stratification in patients of hematological disorders with febrile neutropenia","volume":"33","author":"Taj","year":"2017","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"4","key":"10.1016\/j.esmoop.2022.100743_bib23","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0959-8049(99)00319-6","article-title":"Measuring comorbidity in older cancer patients","volume":"36","author":"Extermann","year":"2000","journal-title":"Eur J Cancer"},{"issue":"22","key":"10.1016\/j.esmoop.2022.100743_bib24","doi-asserted-by":"crossref","first-page":"7996","DOI":"10.1002\/cam4.4316","article-title":"Evidence to guide the optimal timing for pre-chemotherapy blood tests for early breast, colorectal cancer and diffuse large B-cell lymphoma","volume":"10","author":"Chambers","year":"2021","journal-title":"Cancer Med"}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702922003775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702922003775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:29:42Z","timestamp":1761856182000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2059702922003775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S2059702922003775"],"URL":"https:\/\/doi.org\/10.1016\/j.esmoop.2022.100743","relation":{},"ISSN":["2059-7029"],"issn-type":[{"value":"2059-7029","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of a risk score (Delay-7) to predict the occurrence of a treatment delay following cycle 1 chemotherapy","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmoop.2022.100743","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100743"}}